Filip de Vos

Assistant Professor - medical

Strategic program(s):

Biography

Education

1993 – 1996

1996 – 2000

2004

2010

Pre-MedicalSchool at Limburg UniversityCenter, Hasselt, Belgium

MedicalSchool at University of Antwerp, Antwerp, Belgium (MD)

PhD thesis: “Balance between desired and unwanted effects of chemotherapeutic and anti-angiogenic drugs” at department of Medical Oncology at the University of Groningen, The Netherlands

Degree: Medical Oncologist, University of Rotterdam, The Netherlands

Additional training

2013

2014

12th Masterclass in Clinical Oncology by the European School of

Oncology (ESO) and European Society of Medical Oncology

(ESMO)

Clinical Trial Statistics for Non-Statisticians by the European

Organization for Research and Treatment in Cancer (EORTC)

Basic Course Legislation and Organization for Clinical Researchers

(BROK)

Professional experience

2008 – 2010

2010 – 2011

2011 – present

Fellow, Dept of Medical Oncology, ErasmusMedical Center, Rotterdam, The Netherlands

Staff member, Dept of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Staff member, Dept of Medical Oncology, University of Utrecht, Utrecht, the Netherlands

Since start of PhD thesis extensive experience with clinical trials

Strategic program(s):

Contact

fvos@umcutrecht.nl

Pure profile

Research groups

Clinical and translational neuro-oncology

Research aim

We aim to improve treatments and clinical outcomes of patients with gliomas and other brain tumors, by combining expertise from oncobiology, neuropsychology, imaging, surgical & clinical neurology, and palliative care.

Go to group

Recent publications

All publications

Educational needs in neuro-oncology Oriol Mirallas, Giulia Cerretti, Anna Sophie Berghoff, Dieta Brandsma, Filip De Vos, Julia Furtner, Norbert Galldiks, Giuseppe Lombardi, Slavka Lukacova, Evangelia Razis, Ghazaleh Tabatabai, Emilie Le Rhun, Enrico Franceschi, Giuseppe Minniti
Neuro-oncology advances, 2026, vol. 8, p.1-9

European neuro-oncology quality assessment (ENOQUA) Evangelia Razis, Thierry Gorlia, Matthias Preusser, Jean-François Daisne, Ludo Vanopdenbosch, Patrick Roth, Maximilian J Mair, Markus Wolfram Gross, Vittoria Espeli, Tomas Kazda, Jordi Bruna, Andrea Di Cristofori, Giuseppe Lombardi, Egils Valeinis, Dieta Brandsma, Annika Malmstrom, Petter Brandal, Ana Azevedo, Naureen Keric, Philipp Lohmann, Anastasia Vernadou, Brigitta Gertrud Baumert, Nicolaus Andratschke, Michael Weller, Filip de Vos, Peter Hau
Neuro-Oncology Practice, 2026, vol. 13, p.518-527

Understanding the unmet needs of patients with brain metastases referred for stereotactic radiotherapy and their caregivers Fia Cialdella, Eva E van Grinsven, Steven H J Nagtegaal, Arthur T J van der Boog, Celeste C Hinkert, Marion G Jentink, Ernst J Smid, An Claes, Catharina E Kleynen, Tom J Snijders, Filip Y F de Vos, Marielle E P Philippens, Martine J E van Zandvoort, Szabolcs David, Joost J C Verhoeff
Neuro-Oncology Practice, 2026, vol. 13, p.262-275

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer Maarten A Huismans, Eelke H Gort, Lisa T van der Heijden, Sermin M Guven Mese, Helena M Klein Wolterink, Manon N G J A Braat, Sjoerd G Elias, Filip Y F L de Vos, Lot A Devriese, Henk M W Verheul, Frans L Opdam, Miriam Koopman, Hilde H Nienhuis, Heleen A Crommelin, Hugo J G Snippert, Alwin D R Huitema, Jeanine M L Roodhart
British Journal of Cancer, 2026, vol. 134, p.1744-1753

BRAFV600E-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery Protocol Soemeya F Haj Mohammad, Ilse A C Spiekman, Karlijn Verkerk, Florentine A J Verbeek, Hans Timmer, Maud A van Maren, Laurien J Zeverijn, Birgit S Geurts, Antonios Daletzakis, Paul Roepman, Anne M L Jansen, Wendy W J de Leng, Sybren L N Maas, Filip Y F L de Vos, Henk M W Verheul, Emile E Voest, Hans Gelderblom
European Journal of Cancer, 2026, vol. 238

Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG) A M de Jong, A T J van der Boog, C C B Post, F Cialdella, D B P Eekers, J Hendrikse, M C A Kramer, F J Lagerwaard, M van der Meulen, M E P Philippens, P A Robe, T Rozema, F Y F L de Vos, J Vos-Westerman, H L van der Weide, G Wester, J Zindler, T J Snijders, J J C Verhoeff
PLoS ONE, 2026, vol. 21

External positions

Member or Chair of diverse groups - Quality of Neuro-oncology care group; Protocol rare brain tumors, glioma, spinal and brain metastas - LWNO

lid werkgroep Richtlijnen Palliatieve Zorg - coordinatie/organisatie richtlijnen rondom palliatieve zorg - NIV